English
  • head_banner_01
professional factory for Carbetocin Pharmacology - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex Featured Image
  • professional factory for Carbetocin Pharmacology - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex

professional factory for Carbetocin Pharmacology - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Our mission will be to become an innovative supplier of high-tech digital and communication devices by furnishing benefit added structure, world-class manufacturing, and service capabilities for Sodium Stearate, Tiotropium Bromide, Cetrorelix Acetate, On account of superior excellent and aggressive rate , we will be the sector leader, make sure you don’t hesitate to contact us by cellular phone or email, if you're fascinated in almost any of our items.
professional factory for Carbetocin Pharmacology - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex Detail:

Product Detail

NO.

Products

CAS No.

 Application

Key Quality Indicator

Purity

Isomer

SI *

Max *

Moisture

1

 Fmoc-Lys(Mtt)-OH 167393-62-6 Lysine side chain modification

≥99.0%

≤0.1%

≤0.2%

≤0.3%

≤1.0%

2

 Fmoc-Lys(Alloc)-OH 146982-27-6 Lysine side chain modification

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

3

 Fmoc-Lys(ivDde)-OH 150629-67-7 Lysine side chain modification

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

4

 Fmoc-Lys(Mmt)-OH 159857-60-0 Lysine side chain modification

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

5

 Fmoc-Glu-OtBu 84793-07-7 LiraglutideSemaglutide

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

6

 Glu-OtBu 45120-30-7 LiraglutideSemaglutide

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

7

 Octadecanedioic acid 871-70-5 Semaglutide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

8

 Octadecanedioic acid   mono-tert-butyl ester 843666-40-0 Semaglutide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

9

 tBu-OOC-C16-CO-Glu-OtBu 1188328-39-3 SemaglutideFragment A

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

10

 AEEA 134978-97-5 SemaglutideAlbuvirtide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

11

 AEEA-OH.HCl 134979-01-4 SemaglutideAlbuvirtide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

12

 Fmoc-AEEA-OH 166108-71-0 SemaglutideAlbuvirtide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

13

 Boc-AEEA-OH 108466-89-3 Semaglutide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

14

 AEEA-AEEA 1143516-05-5 Semaglutide

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

15

 Fmoc-AEEA-AEEA-OH 560088-89-3 SemaglutideFragment B

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

16

 Octa(OtBu)-Glu(ɑ-OtBu)-AEEA-AEEA-OH 1118767-16-0 SemaglutideFragment C

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

17

 tBu-OOC-C16-CO-Glu(AEEA-AEEA-NHS)-OtBu 1118767-15-9 SemaglutideFragment D

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

18

 Fmoc-Lys(tBu-OOC-C16-CO-Glu(AEEA-AEEA)-OtBu)-OH 1662688-20-1 Semaglutide Fragment E

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

19

 Boc-His(Trt)-OH 32926-43-5 The end is histidine

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤4.0%

20

 Fmoc-Aib-OH 94744-50-0 Semaglutide

≥99.5%

/

≤0.1%

≤0.2%

≤1.0%

21

 Boc-His(Trt)-Aib-OH 2061897-68-3 Semaglutide

≥99.0%

≤0.1%

≤0.2%

≤0.3%

≤2.0%

22

 Fmoc-Glu(OtBu)-Gly-OH 866044-63-5 GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

23

 Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH 1169630-31-2？ Semaglutide Fragment F

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

24

 Boc-His(Trt)-Aib-Glu(OtBu)-Gly-NHS 1169630-40-3 Semaglutide Fragment G

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

25

 Fmoc-Arg(pbf)-Gly-OH 660846-80-0 GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

26

 Fmoc-Ala-Ala-OH 87512-31-0 GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

27

 Fmoc-Thr(tBu)-Phe-OH 1260609-75-3 ? GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

28

 Palmitic acid 1957/10/3 Liraglutide Fragment 1

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

29

 Palm-Glu-OtBu NA Liraglutide Fragment 2

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

30

 Palm-Glu(NES)-OtBu NA Liraglutide Fragment 3

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

31

 Fmoc-Lys(Palm-Glu-OtBu)-OH 1491158-62-3 Liraglutide

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

32

 Hexadecanedioic acid 505-54-4 Insulin degludec

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

33

 Hexadecanedioic acid   mono-tert-butyl ester 843666-27-3 Insulin degludec

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

34

 tBu-OOC-C14-CO-Glu-OtBu NA Insulin degludec Fragment I

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

35

 tBu-OOC-C14-CO-Glu(NES)-OtBu NA Insulin degludec Fragment II

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

SI *= Specific Impurity

Max*= Max Unknown Impurity

Other Indicator:

- Acetic Acid: ≤0.02% (All Products)

- Ethyl Acetate: ≤0.5% (All Products)

- Alcohol: ≤0.5% (All Products)

Sanitization

Sanitization of distribution system, including loop and storage tank is performed by Pasteurization. When Pasteurization sanitization is performed, the purified water in tank is heated up to 80°C and start to circulate by distribution system. The sanitization lasts 1 hour after reaching 80°C. Sanitization is performed every quarter. The purified water system sanitization logbook was checked with no excursion highlighted.

Product detail pictures:

professional factory for Carbetocin Pharmacology - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex detail pictures

Related Product Guide:
We always work as a tangible team to ensure that we can provide you with the best quality and the best price for professional factory for Carbetocin Pharmacology - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex , The product will supply to all over the world, such as: Australia, Finland, Sydney, Our solutions have national accreditation requirements for qualified, good quality items, affordable value, was welcomed by individuals all over the world. Our goods will continue to improve inside the order and appear forward to cooperation with you, Really should any of those items be of interest to you, please letus know. We will be satisfied to provide you a quotation up on receipt of the detailed needs.
    • This is the first business after our company establish, products and services are very satisfying, we have a good start, we hope to cooperate continuous in the future!
    5 Stars By Donna from Slovak Republic - 2018.03.03 13:09
    With a positive attitude of "regard the market, regard the custom, regard the science", the company works actively to do research and development. Hope we have a future business relationships and achieving mutual success.
    5 Stars By Helen from Sudan - 2017.03.28 16:34
    Write your message here and send it to us

    Related PRODUCTS

    Hit enter to search or ESC to close